Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer

Nanocarriers as an emerging platform for cancer therapy

Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710 · see citing works

Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications

Esfand, R., & Tomalia, D. A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01757-3 · Cited by 1,562 · see citing works

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

Li, D., Ambrogio, L., Shimamura, T., Kubo, S., Takahashi, M., Chirieac, L. R., Padera, R. F., Shapiro, G. I., Baum, A., Himmelsbach, F., et al. (2008) · Oncogene · doi:10.1038/onc.2008.109 · Cited by 1,447 · see citing works

Tumor angiogenesis and vascular normalization: alternative therapeutic targets

Viallard, C., & Larrivée, B. (2017) · Angiogenesis · doi:10.1007/s10456-017-9562-9 · Cited by 1,435 · see citing works

Polyamidoamine cascade polymers mediate efficient transfection of cells in culture

Haensler, J., & Szoka, F. C. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00023a012 · Cited by 1,208 · see citing works

Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis

Noguera‐Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Lin, H. C., Yancopoulos, G. D., & Thurston, G. (2006) · Nature · doi:10.1038/nature05355 · Cited by 1,032 · see citing works

Survivin, cancer networks and pathway-directed drug discovery

Altieri, D. C. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2293 · Cited by 998 · see citing works

Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy

Cantelmo, A. R., Conradi, L.-C., Brajic, A., Goveia, J., Kalucka, J., Pircher, A., Chaturvedi, P., Hol, J., Thienpont, B., Teuwen, L.-A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.006 · Cited by 659 · see citing works

Differential Roles of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Angiogenesis

Shibuya, M. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.5.469 · Cited by 623 · see citing works

A PEGylated dendritic nanoparticulate carrier of fluorouracil

Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544 · see citing works

Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.

Tannock, I. F., Lee, C. M., Tunggal, J. K., Cowan, D., & Egorin, M. J. (2002) · PubMed · Cited by 505 · see citing works

Chloroquine in Cancer Therapy: A Double-Edged Sword of Autophagy

Kimura, T., Takabatake, Y., Takahashi, A., & Isaka, Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2464 · Cited by 494 · see citing works

Tumor Vessel Normalization by Chloroquine Independent of Autophagy

Maes, H., Kuchnio, A., Peric, A., Moens, S., Nys, K., Bock, K. D., Quaegebeur, A., Schoors, S., Γεωργιάδου, Μ., Wouters, J., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.025 · Cited by 411 · see citing works

Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery

Kesharwani, P., & Iyer, A. K. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.012 · Cited by 382 · see citing works

Up-regulation of Delta-like 4 Ligand in Human Tumor Vasculature and the Role of Basal Expression in Endothelial Cell Function

Patel, N. S., Li, J.-L., Generali, D., Poulsom, R., Cranston, D. W., & Harris, A. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1208 · Cited by 349 · see citing works

A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas

Li, Y., He, H., Jia, X., Lü, W.-L., Lou, J., & Wei, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.004 · Cited by 310 · see citing works

PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors

He, H., Li, Y., Jia, X., Du, J., Ying, X., Lü, W.-L., Lou, J., & Wei, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.002 · Cited by 303 · see citing works

Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels

Fonsatti, E., Altomonte, M., Nicotra, M. R., Natali, P. G., & Maio, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206813 · Cited by 241 · see citing works

Accumulating nanoparticles by EPR: A route of no return

Ngoune, R., Peters, A., von Elverfeldt, D., Winkler, K., & Pütz, G. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.028 · Cited by 221 · see citing works

Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer

Li, F., Mei, H., Gao, Y., Xie, X., Nie, H., Li, T., Zhang, H., & Jia, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.030 · Cited by 152 · see citing works

A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery

Wolfram, J., Nizzero, S., Liu, H., Li, F., Zhang, G., Li, Z., Shen, H., Blanco, E., & Mauro Ferrari, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-14221-2 · Cited by 145 · see citing works

Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer

Shen, J., Yin, Q., Chen, L., Zhang, Z., & Li, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.007 · Cited by 142 · see citing works

Pharmacodynamic Separation of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Chemotherapy in Non–Small-Cell Lung Cancer

Davies, A. M., Ho, C., Lara, P. N., Mack, P. C., Gumerlock, P. H., & Gandara, D. R. (2006) · Clinical Lung Cancer · doi:10.3816/clc.2006.n.021 · Cited by 130 · see citing works

Epidermal Growth Factor Receptor Inhibition Modulates the Microenvironment by Vascular Normalization to Improve Chemotherapy and Radiotherapy Efficacy

Cerniglia, G. J., Pore, N., Tsai, J. H., Schultz, S. M., Mick, R., Choe, R., Xing, X., Durduran, T., Yodh, A. G., Evans, S. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006539 · Cited by 125 · see citing works

Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies

Pascolo, S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.017 · Cited by 116 · see citing works

Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers

Mercier, M.-C., Dontenwill, M., & Choulier, L. (2017) · Cancers · doi:10.3390/cancers9060069 · Cited by 113 · see citing works

Targeting of cancer-associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment

Li, M., Li, M., Yin, T., Shi, H., WEN, Y., Zhang, B., Chen, M., Xu, G., Ren, K., & Wei, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4868 · Cited by 103 · see citing works

Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma

Krepela, E. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000464 · Cited by 100 · see citing works

Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer

Tong, C. W. S., Wu, W. K. K., Loong, H. H.-F., Cho, W. C. S., & To, K. K. W. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.023 · Cited by 100 · see citing works

Aptamer-targeted delivery of Bcl-xL shRNA using alkyl modified PAMAM dendrimers into lung cancer cells

Ayatollahi, S., Salmasi, Z., Hashemi, M., Askarian, S., Oskuee, R. K., Abnous, K., & Ramezani, M. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.005 · Cited by 96 · see citing works

MicroRNA‐203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin

Bian, K., Fan, J., Zhang, X., Yang, X., Zhu, H., Wang, L., Sun, J., Meng, Y., Cui, P., Cheng, S.-Y., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.01.050 · Cited by 84 · see citing works

Developmental expression of LC3α and β: Absence of fibronectin or autophagy phenotype in LC3β knockout mice

Cann, G. M., Guignabert, C., Ying, L., Deshpande, N., Bekker, J. M., Wang, L., Zhou, B., & Rabinovitch, M. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21392 · Cited by 84 · see citing works

Cellular uptake of self-assembled cationic peptide–DNA complexes: Multifunctional role of the enhancer chloroquine

Yang, S., Coles, D. J., Esposito, A., Mitchell, D. J., Tóth, I., & Minchin, R. F. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.12.015 · Cited by 80 · see citing works

Role of Survivin in EGFR Inhibitor–Induced Apoptosis in Non–Small Cell Lung Cancers Positive for EGFR Mutations

Okamoto, K., Okamoto, I., Okamoto, W., Tanaka, K., Takezawa, K., Kuwata, K., Yamaguchi, H., Nishio, K., & Nakagawa, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2438 · Cited by 79 · see citing works

iRGD Conjugated TPGS Mediates Codelivery of Paclitaxel and Survivin shRNA for the Reversal of Lung Cancer Resistance

Shen, J., Meng, Q., Sui, H., Yin, Q., Zhang, Z., Yu, H., & Li, Y. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400576f · Cited by 69 · see citing works

Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin

Okamoto, K., Okamoto, I., Hatashita, E., Kuwata, K., Yamaguchi, H., Kita, A., Yamanaka, K., Ono, M., & Nakagawa, K. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0638 · Cited by 68 · see citing works

Anticancer Effects of Paris Saponins by Apoptosis and PI3K/AKT Pathway in Gefitinib-Resistant Non-Small Cell Lung Cancer

Zhu, X., Jiang, H., Li, J., Ji, X., & Fei, Z. (2016) · Medical Science Monitor · doi:10.12659/msm.898558 · Cited by 68 · see citing works

Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides

Moore, N. M., Sheppard, C. L., & Sakiyama‐Elbert, S. E. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2008.09.009 · Cited by 63 · see citing works

The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures

Fan, J., Wang, L., Jiang, G., He, W., & Ding, J.-A. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.11.011 · Cited by 58 · see citing works

Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery

Kim, S. J., Jung, K. H., Son, M. K., Park, J. H., YAN, H. H., Fang, Z., Kang, Y. W., Han, B., Lim, J. H., & Hong, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.035 · Cited by 58 · see citing works

Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticles

Gao, Y., Chen, L., Zhang, Z., Chen, Y., & Li, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.001 · Cited by 57 · see citing works

DNA aptamers that target human glioblastoma multiforme cells overexpressing epidermal growth factor receptor variant III in vitro

Tan, Y. H., Shi, Y., Wu, X., Liang, H., Gao, Y., Li, S.-J., Zhang, X., Wang, F., & Gao, T. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.137 · Cited by 56 · see citing works

Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury

Cheng, X. Y., Gu, X., Gao, Q. F., ZONG, Q. F., Li, X. H., & Zhang, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5345 · Cited by 55 · see citing works

Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR

Hwang, K., Kwon, S., Kim, Y. S., Park, D., Kim, B.-R., Yoon, K., Jeong, E., & Kim, H.-R. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.02.026 · Cited by 52 · see citing works

Bioreducible poly (β-amino esters)/shRNA complex nanoparticles for efficient RNA delivery

Yin, Q., Gao, Y., Zhang, Z., Zhang, P., & Li, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.12.014 · Cited by 50 · see citing works

Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response

Zhang, X., Maity, T. K., Kashyap, M. K., Bansal, M., Venugopalan, A. K., Singh, S., Awasthi, S., Marimuthu, A., Jacob, H. K. C., Belkina, N., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m117.067439 · Cited by 50 · see citing works

CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas

Venkataramani, V., Küffer, S., Cheung, K. C. P., Jiang, X., Trümper, L., Wulf, G. G., & Ströbel, P. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1778 · Cited by 50 · see citing works

The Role of Irreversible HER Family Inhibition in the Treatment of Patients with Non-Small Cell Lung Cancer

Kwak, E. L. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0087 · Cited by 44 · see citing works

Nanoparticles target early-stage breast cancer metastasisin vivo

Goldman, E., Zinger, A., da Silva, D., Yaari, Z. A., Kajal, A., Vardi‐Oknin, D., Goldfeder, M., Schroeder, J. E., Shainsky‐Roitman, J., Hershkovitz, D., et al. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa8a3d · Cited by 40 · see citing works

Modeling of Tumor Progression in NSCLC and Intrinsic Resistance to TKI in Loss of PTEN Expression

Bidkhori, G., Moeini, A., & Masoudi‐Nejad, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048004 · Cited by 38 · see citing works

Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

Santarpía, M., Gil, N., & Rosell, R. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.1055252 · Cited by 34 · see citing works

Novel Thermoresponsive Nonviral Gene Vector: P(NIPAAm-co-NDAPM)-b-PEI with Adjustable Gene Transfection Efficiency

Cheng, H. L., Zhu, J., Sun, Y., Cheng, S., Zhang, X., & Zhuo, R. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700478s · Cited by 31 · see citing works

Chaetoglobosin K inhibits tumor angiogenesis through downregulation of vascular epithelial growth factor-binding hypoxia-inducible factor 1α

Luo, H., Li, B., Li, Z., Cutler, S. J., Rankin, G. O., & Chen, Y. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283627a0b · Cited by 31 · see citing works

Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent

Chauhan, A. (2015) · Microbes and Infection · doi:10.1016/j.micinf.2015.05.006 · Cited by 27 · see citing works

The EGFR Pathway Regulates BCRP Expression in NSCLC Cells: Role of Erlotinib

Porcelli, L., Giovannetti, E., Assaraf, Y. G., Jansen, G., Scheffer, G. L., Kathmann, I., Azzariti, A., Paradiso, A., & Peters, G. J. (2014) · Current Drug Targets · doi:10.2174/1389450116666141205145620 · Cited by 27 · see citing works

Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes.

Mason, R. P., Corbalan, J. J., Jacob, R. F., Dawoud, H., & Maliñski, T. (2015) · PubMed · Cited by 26 · see citing works

Microvessel area of immature vessels is a prognostic factor in renal cell carcinoma

Sato, M., Nakai, Y., Nakata, W., Yoshida, T., Hatano, K., Kawashima, A., Fujita, K., Uemura, M., Takayama, H., & Nonomura, N. (2013) · International Journal of Urology · doi:10.1111/iju.12231 · Cited by 24 · see citing works

Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression

Liu, M., Xiong, S., Tan, F., & Liu, Y. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.152 · Cited by 24 · see citing works

Rheumatoid Arthritis Fibroblast-like Synoviocyte Suppression Mediated by PTEN Involves Survivin Gene Silencing

Chen, D., Liu, D., Liu, D., He, M. Y., Peng, A., Xu, J., Lin, L., Luo, F., Chen, L., Zhuang, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00517-w · Cited by 24 · see citing works

Angiogenesis and antiangiogenic agents in non-small cell lung cancer

Galligioni, E., & Ferro, A. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00386-5 · Cited by 23 · see citing works

Induction of Survivin Inhibition, G2/M Cell Cycle Arrest and Autophagic on Cell Death in Human Malignant Glioblastoma Cells

Tang, T.-K. (2015) · The Chinese Journal of Physiology · doi:10.4077/cjp.2015.bac267 · Cited by 19 · see citing works

How to teach an old dog new tricks: Autophagy-independent action of chloroquine on the tumor vasculature

Maes, H., Kuchnio, A., Carmeliet, P., & Agostinis, P. (2014) · Autophagy · doi:10.4161/auto.36259 · Cited by 17 · see citing works

Small interfering RNA targeting of the survivin gene inhibits human tumor cell growth in vitro

Zhang, Z., Wang, T., Liu, Z., Tang, S.-Q., Yue, M., Feng, S., Hu, M., Xuan, L., & Chen, Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4501 · Cited by 14 · see citing works

Green fluorescent protein as indicator of nonviral transient transfection efficiency in endometrial and testicular biopsies

Zizzi, A., Minardi, D., Ciavattini, A., Giantomassi, F., Montironi, R., Muzzonigro, G., Primio, R. D., & Lucarini, G. (2009) · Microscopy Research and Technique · doi:10.1002/jemt.20779 · Cited by 11 · see citing works

Highly water-soluble, pH sensitive and biocompatible PAMAM ‘dendrizyme’ to maintain catalytic activity in complex medium

Wang, L., Cui, Y., Chen, S., Wang, G., Gao, D., Liu, Y., Luo, Q., Liu, Z., & Zhang, X. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.02.144 · Cited by 11 · see citing works

Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non-small cell lung cancer cells

Huang, Q., Zeng, Y., Lin, H., Zhang, H., & Yang, D. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7490 · Cited by 11 · see citing works

Downregulation of Survivin by shRNA Inhibits Invasion and Enhances the Radiosensitivity of Laryngeal Squamous Cell Carcinoma

Hu, J., Pan, J., Luo, Z., & Tao, Z. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0445-z · Cited by 10 · see citing works

The comparison of EGFR-TKI failure modes and subsequent management between exon 19 deletion and exon 21 L858R mutation in advanced non-small-cell lung cancer

Zhang, Y., Chen, G., Chen, X., Fang, W., Gao, F., Yang, Y., Zhao, Y., Ma, Y., Hong, S., Zhang, Z., et al. (2017) · Journal of Cancer · doi:10.7150/jca.19867 · Cited by 10 · see citing works

Construction and identification of multiple genes Co silence of plasmid shRNA.

Sun, J., Wang, L., Mingmin, D., Cao, H., & Tian, X. (2015) · PubMed Central · Cited by 3 · see citing works

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works

Autophagy as a molecular target for cancer treatment

Kocatürk, N. M., Akkoç, Y., Kığ, C., Bayraktar, O., Gözüaçık, D., & Kutlu, Ö. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.011 · Cited by 388 · see citing works

In vivo gene delivery mediated by non-viral vectors for cancer therapy

Mohammadinejad, R., Dehshahri, A., Madamsetty, V. S., Zahmatkeshan, M., Tavakol, S., Makvandi, P., Khorsandi, D., Pardakhty, A., Ashrafizadeh, M., Afshar, E. G., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.038 · Cited by 238 · see citing works

PAMAM dendrimer as a talented multifunctional biomimetic nanocarrier for cancer diagnosis and therapy

Surekha, B., Kommana, N. S., Dubey, S. K., Kumar, A. V. P., Shukla, R., & Kesharwani, P. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.111837 · Cited by 175 · see citing works

Targeting Autophagy for Cancer Treatment and Tumor Chemosensitization

Pérez-Hernández, M., Arias, A., Martínez‐García, D., Pérez‐Tomás, R., Quesada, R., & Soto‐Cerrato, V. (2019) · Cancers · doi:10.3390/cancers11101599 · Cited by 152 · see citing works

The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy

Liu, S., Khan, A. R., Yang, X., Dong, B., Ji, J., & Zhai, G. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.012 · Cited by 140 · see citing works

Nanoparticle drug delivery systems for synergistic delivery of tumor therapy

Chen, D., Liu, X., Lu, X., & Tian, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1111991 · Cited by 132 · see citing works

Aptamer-Based Targeted Delivery of Functional Nucleic Acids

Xie, S., Sun, W., Fu, T., Liu, X., Chen, P., Qiu, L., Qu, F., & Tan, W. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c00841 · Cited by 130 · see citing works

Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer

Wathoni, N., Puluhulawa, L. E., Joni, I. M., Muchtaridi, M., Mohammed, A. F. A., Elamin, K. M., Milanda, T., & Gozali, D. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2120566 · Cited by 107 · see citing works

Nanomedicine Combats Drug Resistance in Lung Cancer

Zheng, X., Song, X.-H., Zhu, G., Pan, D., Li, H., Hu, J., Xiao, K., Gong, Q., Gu, Z., Luo, K., et al. (2023) · Advanced Materials · doi:10.1002/adma.202308977 · Cited by 88 · see citing works

Near-infrared/pH dual-responsive nanocomplexes for targeted imaging and chemo/gene/photothermal tri-therapies of non-small cell lung cancer

Li, Z., Zhu, L., Liu, W., Zheng, Y., Li, X., Ye, J., Li, B., Chen, H., & Gao, Y. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.03.004 · Cited by 67 · see citing works

Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg?

Mattheolabakis, G., & Mikelis, C. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01227 · Cited by 63 · see citing works

Tumor microenvironment and nanotherapeutics: intruding the tumor fort

Kiran, A. V. V. V. R., Kumari, G. K., Krishnamurthy, P. T., & Khaydarov, R. R. (2021) · Biomaterials Science · doi:10.1039/d1bm01127h · Cited by 60 · see citing works

Wireless electrical stimulation at the nanoscale interface induces tumor vascular normalization

Li, C., Xiao, C., Zhan, L., Zhang, Z., Xing, J. Q., Zhai, J., Zhou, Z., Tan, G., Piao, J., Zhou, Y., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.03.027 · Cited by 60 · see citing works

Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: Biological strategy, design and quality control

Nguyen, P.-V., Allard-Vannier, É., Chourpa, I., & Hervé-Aubert, K. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120795 · Cited by 57 · see citing works

Application of Nanoparticles in the Treatment of Lung Cancer With Emphasis on Receptors

Wang, J., Zhou, T., Liu, Y., Chen, S., & Yu, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.781425 · Cited by 57 · see citing works

DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors

Shishparenok, A. N., Furman, V. V., & Zhdanov, D. D. (2023) · Cancers · doi:10.3390/cancers15072151 · Cited by 50 · see citing works

Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead

Akhter, M. H., Beg, S., Tarique, M., Malik, A., Afaq, S., Choudhry, H., & Hosawi, S. B. I. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129777 · Cited by 49 · see citing works

Nanomedicine of tyrosine kinase inhibitors

Šmídová, V., Michálek, P., Goliášová, Z., Eckschlager, T., Hodek, P., Adam, V., & Heger, Z. (2020) · Theranostics · doi:10.7150/thno.48662 · Cited by 47 · see citing works

Co-delivery Systems of Multiple Drugs Using Nanotechnology for Future Cancer Therapy

Fumoto, S., & Nishida, K. (2020) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c20-00008 · Cited by 43 · see citing works

Two Faces of Autophagy in the Struggle against Cancer

Kubicka, A., Matczak, K., & Marczak, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062981 · Cited by 43 · see citing works

Nano drug delivery system reconstruct tumour vasculature for the tumour vascular normalisation

Liang, Q., Zhou, L., Li, Y., Liu, J., & Liu, Y. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1927056 · Cited by 41 · see citing works

Effect of Oxaliplatin-Loaded Poly (d,l-Lactide-co-Glycolic Acid) (PLGA) Nanoparticles Combined with Retinoic Acid and Cholesterol on Apoptosis, Drug Resistance, and Metastasis Factors of Colorectal Cancer

Oliveira, A. L. C. D. S. L., Júnior, R. F. D. A., de Carvalho, T. G., Chan, A. B., Schomann, T., Tamburini, F., de Geus‐Oei, L., & Cruz, L. J. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020193 · Cited by 39 · see citing works

Tri-component programmable nanoregulator with Three-pronged penetration boosts immunotherapy of Triple-Negative breast cancer

Li, Z., Shi, H., Xie, H., Yang, Y., Zheng, Y., Chen, H., & Gao, Y. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.135712 · Cited by 39 · see citing works

Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy

Fatani, W. K., Aleanizy, F. S., Alqahtani, F. Y., Alanazi, M. M., Aldossari, A. A., Shakeel, F., Haq, N., Abdelhady, H. G., Alkahtani, H. M., & Alsarra, I. A. (2023) · Molecules · doi:10.3390/molecules28093974 · Cited by 38 · see citing works

Delivery of erlotinib for enhanced cancer treatment: An update review on particulate systems

Truong, D. H., Le, V. K. H., Pham, T. T., Dao, A. H., Pham, T. P. D., & Tran, T. H. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101348 · Cited by 36 · see citing works

Realizing Cancer Precision Medicine by Integrating Systems Biology and Nanomaterial Engineering

Joo, J. I., Choi, M., Jang, S., Choi, S. R., Park, S., Shin, D., & Cho, K. (2020) · Advanced Materials · doi:10.1002/adma.201906783 · Cited by 35 · see citing works

AZD9291 Resistance Reversal Activity of a pH‐Sensitive Nanocarrier Dual‐Loaded with Chloroquine and FGFR1 Inhibitor in NSCLC

Gu, Y., Lai, S., Dong, Y., Fu, H., Song, L., Chen, T., Duan, Y., & Zhang, Z. (2020) · Advanced Science · doi:10.1002/advs.202002922 · Cited by 35 · see citing works

Indocyanine green-encapsulated erlotinib modified chitosan nanoparticles for targeted chemo-photodynamic therapy of lung cancer cells

Zhang, L., Wang, J. L., Zhang, Y., Ke, L., Lin, X., Li, Z., Chen, H., & Gao, Y. (2019) · Dyes and Pigments · doi:10.1016/j.dyepig.2019.107588 · Cited by 33 · see citing works

Recent advances in aerosol gene delivery systems using non-viral vectors for lung cancer therapy

Lee, A. Y., Cho, M., & Kim, S. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1641083 · Cited by 33 · see citing works

Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers

Yang, X., Zhao, J., Duan, S., Hou, X., Li, X., Hu, Z., Tang, Z., Mo, F., & Lü, X. (2019) · Theranostics · doi:10.7150/thno.33383 · Cited by 32 · see citing works

Micelle nanovehicles for co-delivery of Lepidium meyenii Walp. (maca) polysaccharide and chloroquine to tumor-associated macrophages for synergistic cancer immunotherapy

Yang, Y. J., Guo, T., Xu, J., Xiong, Y., Cui, X., Ke, Y., & Wang, C. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.08.155 · Cited by 30 · see citing works

A review on RNAi therapy for NSCLC : Opportunities and challenges

KUMAR, V. K., Yadavilli, S., & Kannan, R. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1677 · Cited by 30 · see citing works

Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy

Sanctis, J. B. D., Charris, J., Blanco, Z., Ramírez, H., Martinez, G. P., & Mijares, M. R. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220519102948 · Cited by 29 · see citing works

Transferrin-targeting redox hyperbranched poly(amido amine)-functionalized graphene oxide for sensitized chemotherapy combined with gene therapy to nasopharyngeal carcinoma

Liu, T., Li, J., Wu, X., Zhang, S., Lu, Z., Li, G., Li, J., & Chen, S. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1642421 · Cited by 28 · see citing works

Advances in nanotechnology-based platforms for survivin-targeted drug discovery

George, R., Hehlgans, S., Fleischmann, M., Rödel, C. M., Fokas, E., & Rödel, F. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2077329 · Cited by 28 · see citing works

Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer

Crintea, A., Constantin, A.-M., Motofelea, A. C., Crivii, C. B., Velescu, M. A., Coșeriu, R. L., Ilyés, T., Craciun, A. M., & Silaghi, C. N. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14090466 · Cited by 26 · see citing works

Co-delivery of gefitinib and hematoporphyrin by aptamer-modified fluorinated dendrimer for hypoxia alleviation and enhanced synergistic chemo-photodynamic therapy of NSCLC

Zhu, F., Xu, L., Li, X., Li, Z., Wang, J., Chen, H., Li, X., & Gao, Y. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.106004 · Cited by 26 · see citing works

Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat

Sanati, M., Afshari, A. R., Ahmadi, S. S., Kesharwani, P., & Sahebkar, A. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166720 · Cited by 26 · see citing works

Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine

Bajinka, O., Ouédraogo, S. Y., Golubnitschaja, O., Li, N., & Zhan, X. (2024) · The EPMA Journal · doi:10.1007/s13167-024-00357-5 · Cited by 24 · see citing works

Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer

Bom, A. P. D. A., Neves, P., de Almeida, C. E. B., Silva, D., & Missailidis, S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11120684 · Cited by 23 · see citing works

Dendrimers as drug delivery systems for oncotherapy: Current status of promising applications

Sueyoshi, S., Silva, J. V., Guizze, F., & Giarolla, J. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124573 · Cited by 22 · see citing works

A reactive oxygen/nitrogen species-eliminating natural product-based nanomedicine for prevention and treatment of inflammatory liver injury

Zheng, Y., Du, M., Shi, H., Liu, W., Zhuang, C., Chen, H., & Gao, Y. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.144952 · Cited by 21 · see citing works

Exploration of Site-Specific Drug Targeting—A Review on EPR-, Stimuli-, Chemical-, and Receptor-Based Approaches as Potential Drug Targeting Methods in Cancer Treatment

Rasel, M. S. I., Mohona, F. A., Akter, W., Kabir, S., Chowdhury, A. A., Chowdhury, J. A., Hassan, M. A., Mamun, A. A., Ghose, D. K., Ahmad, Z., et al. (2022) · Journal of Oncology · doi:10.1155/2022/9396760 · Cited by 20 · see citing works

Aptamer-Functionalized ZIF-8 Nanomedicine for Targeted Delivery of Gefitinib and siRNA to Treat Tyrosine-Kinase-Inhibitor-Resistant Nonsmall-Cell Lung Cancer

Liu, M., Sun, C., Jiang, J., Wan, L., Hu, C., Wen, C., Huang, G., Ruan, Q., Wu, S., Qiao, D., et al. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c03564 · Cited by 19 · see citing works

Aptamers in Non-Small Cell Lung Cancer Treatment

Wieleba, I., Wojas‐Krawczyk, K., & Krawczyk, P. A. (2020) · Molecules · doi:10.3390/molecules25143138 · Cited by 18 · see citing works

Nanotechnology Meets the Tumor Microenvironment: Unlocking New Horizons in Cancer Therapy

Yadav, P., Yadav, A. K., & Bhatia, D. D. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01120 · Cited by 16 · see citing works

Advances in Oligonucleotide Aptamers for NSCLC Targeting

Rotoli, D., Santana-Viera, L., Ibba, M. L., Esposito, C. L., & Catuogno, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176075 · Cited by 16 · see citing works

Modulation of Tumor Vasculature Network: Key Strategies

Taleb, M., Mohammadkhani, N., Bahreini, F., Ovais, M., & Nie, G. (2022) · Small Structures · doi:10.1002/sstr.202100164 · Cited by 16 · see citing works

Biointerface engineering of self-protective bionic nanomissiles for targeted synergistic chemotherapy

Zhen, X., Li, L., Jia, L., Zhu, A., Yang, Y., Wang, S., & Xie, X. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.07.023 · Cited by 12 · see citing works

Pulsed-wave Ultrasound Hyperthermia Enhanced Nanodrug Delivery Combined with Chloroquine Exerts Effective Antitumor Response and Postpones Recurrence

Chiang, C., Hsu, Y.-H., Liu, C.-C., Liang, P., Miaw, S., & Lin, W.-L. (2019) · Scientific Reports · doi:10.1038/s41598-019-47345-8 · Cited by 12 · see citing works

Aptamer-Modified Mesoporous Silica Nanoparticle for Nitric Oxide-Enhanced Targeted Sonodynamic Therapy against Lung Cancer

Zheng, F., Zhang, P., Zhang, Y., Long, H., Zhu, F., Chen, H., & Gao, Y. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c00088 · Cited by 10 · see citing works

Chloroquine Inhibition of Autophagy Enhanced the Anticancer Effects of Listeria monocytogenes in Melanoma

Yu, Z., Zhao, Y., Ding, K., He, L., Liao, C., Li, J., Chen, S., Shang, K., Chen, J., Yu, C., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11020408 · Cited by 10 · see citing works

Developing bioinspired delivery systems for enhanced tumor penetration of macromolecular drugs

Yang, J. P., Zeng, Z., Liu, Y., Li, Y., & Xu, X. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113845 · Cited by 9 · see citing works

Harnessing nanotechnology for enhanced delivery of erlotinib: a dynamic duo in cancer treatment

Pahwa, R., Saini, S., Chhabra, J., Goyal, R., Kumar, S., Awasthi, R., & Dureja, H. (2024) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-024-00528-3 · Cited by 8 · see citing works

Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer

Gorachinov, F., Mraiche, F., Moustafa, D. A., Hishari, O., Ismail, Y., Joseph, J. M., Crcarevska, M. S., Dodov, M. G., Geškovski, N., & Goračinova, K. (2023) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.14.23 · Cited by 8 · see citing works

Research progress of co-delivery nanoparticle drug delivery systems in non-small cell lung cancer: A review

Wu, J., Bao, Q., Wang, X., Chen, H., Chen, X., Wen, Y., & Chen, J. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114795 · Cited by 7 · see citing works

Nanoparticles for Cancer Gene Therapy and Imaging

Fernandes, D. A. (2024) · Biomedical Materials & Devices · doi:10.1007/s44174-024-00235-8 · Cited by 6 · see citing works

Unlocking the Molecular Targets in Non-Small-Cell Lung Cancer and a Nanomedicine-Based Remedy

Sarma, K., Akhter, M. H., Alalmaie, A., Ahmad, I., Ansari, M. N., Khalilullah, H., Farhana, S. A., Hussain, S. M., & Aljadaan, A. M. (2025) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2024053289 · Cited by 6 · see citing works

Biologically based strategies for overcoming in vivo barriers with functional nano‐delivery systems

Ahmadzadeh, R., Taheri, S. A., Mohammadi, N., Hjazi, A. M., Menon, S. V., Kadhum, W. R., Kumar, A., Shakir, M. N., Shayan, F. K., & Shirinkami, N. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23782 · Cited by 6 · see citing works

Dual factor coactivatable fluorescent nanosensor with boosted cytoplasmic biomarker accessibility toward selective tumor imaging

Chen, Y., Xing, Y., Wang, Z., Li, L., Wang, H., Tang, S., Cai, K., & Zhang, J. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.115026 · Cited by 6 · see citing works

A molecular beacon-assisted nanotheranostic agent for real-time detection and effective combined management of acquired resistance to EGFR-TKIs

Zhang, P., Long, H., Zhu, F., Li, X., Liao, J., Chen, H., Li, X., & Gao, Y. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.133765 · Cited by 4 · see citing works

A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling

Yang, H., Wang, Z., Gong, L., Huang, G., Chen, D., Li, X., Du, F., lin, J. X., & Yang, X. (2022) · International Journal of Genomics · doi:10.1155/2022/8594658 · Cited by 3 · see citing works

Dendrimers in drug delivery

Mejlsøe, S. L., & Christensen, J. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91668-4.00005-8 · Cited by 3 · see citing works

Enhancing targeted cancer therapy through multiple drug delivery by silk peptide nanoparticles

He, Z., Qi, L., He, X., Han, D., Liao, X., & Cheng, S. (2024) · Nano Select · doi:10.1002/nano.202300176 · Cited by 2 · see citing works

Aptamers as therapeutic targets: prospects and progress in the treatment of cancers

Sansare, Y., Kejamurthy, P., Singh, S., Ayush, A., Khani, K., & Devi, R. (2025) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2025.2512853 · Cited by 2 · see citing works

Advancements in Nanostructured Smart Drug Delivery Systems in Cancer Treatment: Targeted Modification Strategies and Clinical Implications

Tripathi, A., Vaishnaw, B., Jaishwal, P., Samal, P. K., Verma, A., & Singh, N. (2025) · Current Materials Science · doi:10.2174/0126661454366845250618053301 · Cited by 2 · see citing works

Nanoparticulate systems for combination therapies of lung cancer: A review

Moradi, A., Maskoukian, S., Bączek, T., Rabiee, N., Saeb, M. R., Farokhi, M., & Mottaghitalab, F. (2025) · Journal of Nanoparticle Research · doi:10.1007/s11051-025-06233-1 · Cited by 1 · see citing works

Novos sistemas de delivery, uso tecnológico e reposicionamento da cloroquina e hidroxicloroquina: Uma revisão integrativa

Oliveira, C. D. R., Pereira, J. C., Oliveira, L. V. D. C., & Carvalho, A. L. M. (2021) · Research Society and Development · doi:10.33448/rsd-v10i7.16589

Nanoencapsulation of tyrosine kinase inhibitors for oncological therapeutics

Nguyen, H. L., Gupta, R. K., & Nguyen, T. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91229-7.00014-3

Co-delivery of Anticancer Drugs Using Polymer-Based Nanomedicines for Lung and Prostate Cancer Therapy

Peter, S., Naki, T., Alven, S., & Aderibigbe, B. A. (2023) · Springer eBooks · doi:10.1007/978-981-99-2119-5_25

Next-generation nano-photodynamic and chemotherapy combinations: advances, mechanisms, and clinical prospects

Abbas, F., Rahman, M. S., Hasan, M., & Siraj, N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-40431-3.00014-1

Nanovectorisation ciblée de siARNs pour un effet spécifique et synergique à la chimiothérapie dans le traitement des cancers EGFR positifs

Nguyen, P. V. (2021) · doi:10.70675/89cd693aze5bfz4c89z970az88dc498503d0

Supramolecular dendrimers-based nanoplatform for drug delivery: Synthetic strategy

Kamble, P., Bain, A., Bharti, A., Tekade, M., Soni, S., Nagaraja, S., & Tekade, R. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44119-6.00009-4

Aptamer-Conjugated Chitosan-Anchored Liposomal Complexes for Targeted Delivery of Erlotinib to EGFR-Mutated Lung Cancer Cells

Li, F., Mei, H., Xie, X., Zhang, H., Liu, J., Lv, T., Nie, H., Gao, Y., & Jia, L. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0057-9 · Cited by 61 · see citing works

Endothelin-1–Mediated Drug Resistance in EGFR -Mutant Non-Small Cell Lung Carcinoma

Pulido, I., Ollosi, S., Aparisi, S., Becker, J. H., Aliena‐Valero, A., Benet, M., Rodríguez, M. L., López, A. V., Tamayo-Torres, E., Chuliá‐Peris, L., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0141 · Cited by 21 · see citing works

Reversal of EGFR inhibitors’ resistance by co-delivering EGFR and integrin αvβ3 inhibitors with nanoparticles in non-small cell lung cancer

He, F., Wang, Y., Cai, W., Li, M., & Dong, L. (2019) · Bioscience Reports · doi:10.1042/bsr20181259 · Cited by 15 · see citing works

A novel synthetic compound overcomes drug resistance on EGFR (T790M) and cancer stemness in human non‐small cell lung cancer

Pan, P., Chang, C., Liu, K., Chan, Y., Chen, Y., & Chao, J. (2017) · The FASEB Journal · doi:10.1096/fasebj.31.1_supplement.lb181 · Cited by 1 · see citing works

Novel considerations on EGFR-based therapy as a contributor to cancer cell death in NSCLC

Peng, W., Yao, C., Pan, Q., Zhang, Z., Ye, J., Shen, B., Zhou, G., & Fang, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1120278 · Cited by 17 · see citing works